Fujifilm Diosynth names Lars Petersen to replace Martin Meeson as CEO

Fujifilm Diosynth Biotechnologies, the CDMO arm of the Japanese conglomerate Fujifilm, appointed Lars Petersen as president and CEO amid the company’s expansion of its manufacturing business in Europe and the US.

Petersen will replace Martin Meeson, who has held the top job since 2020. The company did not say why Meeson is departing, though a spokesperson told Endpoints News that he separated from the company “amicably and on good terms.”

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

U.S. to set limits on silica exposure first recommended half a century ago

Most people know silica as the mysterious contents of desiccation packets found in vitamin bottles, high-end leather purses, clothing, and other items. But for miners

April 16, 2024

Many Primary Care Docs Unfamiliar With Biologics for Asthma

ANAHEIM, Calif. — Many primary care physicians (PCPs) remain unfamiliar with biologic therapy options for uncontrolled asthma, which impacted the rate at which they referred

November 14, 2023

Gene therapy trial targeting rare form of deafness shows ‘jaw-droppingly good’ results

Two congenitally deaf children can hear for the first time after being treated with gene therapy, according to data presented at a conference Wednesday. The

May 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.